The HSP90 inhibitor HVH-2930 exhibits potent efficacy against trastuzumab-resistant HER2-positive breast cancer.
Park M, Jung E, Park JM, Park S, Ko D, Seo J, Kim S, Nam KD, Kang YK, Farrand L, Hoang VH, Nguyen CT, La MT, Nam G, Park HJ, Ann J, Lee J, Kim YJ, Kim JY, Seo JH.
Park M, et al. Among authors: kim jy, kim yj, kim s.
Theranostics. 2024 Mar 31;14(6):2442-2463. doi: 10.7150/thno.93236. eCollection 2024.
Theranostics. 2024.
PMID: 38646654
Free PMC article.